Last reviewed · How we verify
NCT07130188
Predictors for ACS and Complexity of CAD
trial testing PCI in TG Index in 130 participants. Not yet recruiting.
1 September 2026
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 1 September 2025 |
| Primary completion | 1 September 2026 |
| Estimated completion | 30 December 2026 |
Drugs / interventions tested
- PCI
Conditions studied
- TG Index — all drugs for TG Index →
- TG/HDL-C Ratio — all drugs for TG/HDL-C Ratio →
- Young Population — all drugs for Young Population →
Sponsor
Assiut University
Who can join
Adults 18 to 40, any sex, with TG Index or TG/HDL-C Ratio. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the significance of the Triglyceride index and TG/HDL-C ratio as predictors of acute coronary syndromes in the young population
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07130188
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PCI
Trials testing the same drug.
- NCT06542653 — Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion · recruiting
- NCT06050096 — DCB Treatment in CTO Guided by IVUS · unknown
- NCT06214754 — Efficacy and Safety of Intravascular High-pressure Cutting Balloon Catheters for PCI · NA · completed
- NCT05292651 — Optimal Stent Deployment Strategy of Contemporary Stents · NA · recruiting
- NCT04743245 — Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard. · NA · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07130188 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 19 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07130188.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing